Cefotaxime PCD Pharma Franchise Company
Cafoli Lifecare is a trusted Cefotaxime PCD pharma franchise company offering 9 WHO-GMP certified Cefotaxime formulations manufactured in DCGI-approved facilities. Our range is supplied to franchise partners across India with district-wise monopoly rights.
What is Cefotaxime?
Cefotaxime is a third-generation cephalosporin antibiotic that works by inhibiting bacterial cell-wall synthesis. It is effective against a broad range of Gram-negative and Gram-positive organisms and is used for serious systemic infections. Learn more on PubChem.
Available Cefotaxime Formulations
Our Cefotaxime portfolio spans 9 formulations across the following dosage forms: Injection and Tablets. As a prescription antibiotic, these are supplied against valid prescriptions.
Therapeutic Applications
Cefotaxime is prescribed for serious bacterial infections including septicaemia, pneumonia, meningitis and complicated urinary and skin infections. As a prescription antibiotic it is used under physicians, intensivists, surgeons and paediatricians.
Why Cefotaxime is a High-Potential Molecule for Distributors
Injectable cephalosporins are hospital and critical-care staples with steady institutional demand. Cefotaxime role in serious infections gives franchise partners access to hospital and acute-care procurement channels.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers district-wise monopoly rights, WHO-GMP and DCGI-approved manufacturing, timely supply and complete promotional inputs. With 1000+ franchise partners, we back every associate marketing our Cefotaxime range with reliable support.
References
- PubChem - Cefotaxime
- PubMed - Cefotaxime research
Our formulations of Cefotaxime find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: